Literature DB >> 2207766

Photodynamic therapy of skin and esophageal cancers.

J S McCaughan1.   

Abstract

We report on 27 patients with cutaneous and subcutaneous malignancies and 40 patients with esophageal tumors treated with photodynamic therapy (PDT). Of those patients treated for skin tumors, seven had basal cell, three squamous cell, three malignant melanoma, one liposarcoma, and twelve had breast cancers. One patient had Bowen's disease. Treatment was given either by surface radiation or interstitially. One month after treatment, 48 (67%) of the treatment sessions resulted in a complete response (no clinical evidence of tumor) and 19 (26%) resulted in a partial response (more than a 50% reduction in the number or size of tumors). Of the 15 patients evaluable 12 months after treatment, 31 treatment sessions were evaluated as complete response 1 month after therapy, 15 (48%) of which retained this status at 1 year posttreatment. Esophageal tumors were as follows: 19 adenocarcinomas, 19 squamous carcinomas, and 2 melanomas. Most patients were reendoscoped 2 to 3 days after PDT and repeat endoscopies were performed 1 month after PDT and as needed when symptoms recurred. The goal of therapy was to improve the patient's ability to swallow. At 1 month, the average length of all tumors decreased from 7.0 to 6.1 cm, and the average minimal diameter opening increased from 6 to 9 mm. Of the 35 patients who were evaluable 1 month after PDT, the average diet grade improved from 16 to 32 (i.e., improvement in food intake from a liquid to a soft diet).

Entities:  

Mesh:

Year:  1990        PMID: 2207766     DOI: 10.3109/07357909009012058

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  3 in total

Review 1.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo.

Authors:  W H Boehncke; K König; R Kaufmann; W Scheffold; O Prümmer; W Sterry
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.

Authors:  Ryo Hiramatsu; Shinji Kawabata; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-ichi Miyatake; Toshihiko Kuroiwa; Erhong Hao; M Graça H Vicente
Journal:  J Pharm Sci       Date:  2014-12-26       Impact factor: 3.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.